Manufacturing Next-Generation Therapeutic Modalities
Cell 2026 · 12 November 2026 · 14:25–14:55 · Conference Room 2
Manufacturing Next-Generation Therapeutic Modalities was a session at Cell 2026 on 12 November 2026 in London, with 3 speakers on record.
Speakers
- David Brühlmann — Moderator Global Head of Biologics Technology, Roche
- James Fleming — Panelist Scientist, AstraZeneca
- Maryam Shariatzadeh — Panelist Senior Scientist, Rinri Therapeutics